SecBot SecBot
S-3 ·Filed May 7, 2026

KALA

KALA BIO, Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed6mo ago SEC0001829126-26-004790
Shelf registration, potential dilution
Actionable Insight • Neutral

Monitor for any subsequent prospectus supplement that would detail an actual debt issuance, pricing, and use of proceeds. Until then, this filing is a routine capital markets step with no immediate trading implications.

DirectionNeutral
Confidencemedium
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$3.95
T+0 close · May 7, 2026 · via day close
Latest settled
−81.19%
T+60 · $0.7430
Vs SPY
−86.03%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 8 $3.95entry
  2. T+1 · 6mo ago −1.01%α −1.24% · $3.91
  3. T+5 · 6mo ago −21.77%α −23.24% · $3.09
  4. T+20 · 5mo ago −47.85%α −47.87% · $2.06
  5. T+60 · 3mo ago −81.19%α −86.03% · $0.7430

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

KALA BIO filed an S-3 shelf registration to issue an unlimited amount of senior and subordinated debt securities. The filing is a standard capital markets preparation and does not include any specific offering terms or amounts. As a routine shelf registration with no immediate pricing, the impact is minimal and neutral.

Key Facts

  • Filed S-3 shelf registration for an unlimited aggregate principal amount of debt securities.
  • Includes indentures for both senior and subordinated debt, but no specific terms or amounts are disclosed.
  • No immediate offering or pricing details provided; the filing is preparatory in nature.

Financial Impact

No specific dollar amounts disclosed.

Risk Factors

  • Potential future debt issuance could dilute equity or increase leverage.
  • No specific financial data in the filing to assess need for capital.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001829126-26-004790
Document: kalabio_ex4-5.htm0001829126-26-004790

Track record

10 reports on KALA

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +77.78% at T+60 after the Jun 26, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago NT 10-Q Bearish 7/10 Entry $0.1496 Now $0.1390 +7.09% settles Nov 17
  2. Nov 12, 20264d ago 8-K Bearish 5/10 Entry $0.1388 to $0.1277 Now $0.1390 −0.14% ▲ +8.02% +6.11% vs SPY
  3. Nov 9, 20267d ago 8-K Neutral 4/10 Entry $0.1773 to $0.1710 Now $0.1390 −21.60% ▼ −3.55% −3.19% vs SPY
  4. Oct 19, 202628d ago SC 13G Neutral 3/10 Entry $0.1926 to $0.1897 Now $0.1390 −27.83% ▼ −1.51% −1.84% vs SPY
  5. Sep 24, 20267w ago Press Release Neutral 3/10 Entry $0.5600 to $0.4760 Now $0.1390 −75.18% ▼ −15.00% −15.54% vs SPY
  6. Aug 28, 202611w ago 8-K Bearish 8/10 Entry $0.6901 to $0.6727 Now $0.1390 +79.86% ▲ +2.52% +2.22% vs SPY
  7. Jul 22, 202616w ago 424B5 Bearish 8/10 Entry $0.6103 to $0.6342 Now $0.1390 +77.22% ▼ −3.92% −3.81% vs SPY
  8. Jun 26, 202620w ago EFFECT Bearish 7/10 Entry $2.52 to $2.09 Now $0.1390 +94.48% ▲ +17.06% +18.71% vs SPY
  9. May 7, 202627w ago S-3 Neutral 2/10 Viewing Entry $3.95 to $3.91 Now $0.1390 −96.48% ▼ −1.01% −1.24% vs SPY
  10. Mar 4, 202636w ago Press Release Mixed 6/10 Entry $17.25 to $0.2750 Now $0.1390 −99.19% ▼ −98.41% −97.83% vs SPY
Showing 10 of 10

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026